IgAN late-breakers led the meeting, alongside new data on aspirin, dialysis access, donor pregnancy, potassium, and depression.
|Videos|May 26, 2016
Houmam Araj from the National Eye Institute: Treating Cataracts A Continuing Focus of Eye Care
Author(s)Amy Jacob
Cataracts are one of the most common diagnosis in eye care but there is still work being done to help treat the condition in the most effective way possible.
Advertisement
Cataracts are one of the most common diagnosis in eye care but there is still work being done to help treat the condition in the most effective way possible.
Houmam Araj, PhD, from the National Eye Institute discussed some of the recent developments in this field during the annual meeting of the Association for Research in Vision and Ophthalmology in Seattle. With a focus on funding research to treat blinding diseases Araj said cataracts affect close to 20 million people making it a high priority to treat in the field.
Advertisement
Related to this article
Five CHEST 2026 interviews cover nalbuphine ER for IPF cough, tozorakimab in COPD, depemokimab remission, AD109 in OSA, and robotic bronchoscopy.
Stephen Seliger, MD, and Michel Chonchol, MD, join Kidney Compass to discuss a pilot trial of empagliflozin in rapidly progressing ADPKD.
In the SCENARIO trial, a 15-week weight-loss program cut recurrent vascular events by 67% in patients with obesity after minor ischemic stroke or TIA.
In PHINDER, IPF had the highest PVD-B65 mortality risk scores. Rali discusses why PH in ILD is missed and when to refer for right heart catheterization.
Parth Rali, MD, explains how the AHA/ACC A-through-E categories compare with ESC risk tiers and how hospitals can meet the class 1 PERT recommendation.
Colin Church, MBBS, PhD, discusses durable 6MWD and NT-proBNP signals in a TPIP open-label extension and what phase 3 needs to show next.
Colin Church, MBBS, PhD, discusses 24-month open-label extension data showing TPIP remains tolerable in patients with PH-ILD, with no new safety signals.
Advertisement
Advertisement
Trending on HCPLive
1
Nalbuphine ER Rapidly Eases IPF Cough Burden, With Phil Molyneaux, MD, PhD
2
Sarcoidosis Care Starts With Inflammation vs Fibrosis: Rohit Gupta, MD
3
Voceryq Gains FDA Accelerated Approval for Recurrent Respiratory Papillomatosis
4
HCPLive Five at CHEST 2026
5